Current location:


Choose your location:

  • R&D Platform

    The company always attaches great importance to R&D and innovation. At present, the company has a research and development team of more than 150 people, the proportion of masters and doctors is ab


  • Pipeline Products

    The company currently has more than 10 varieties under research, mainly including DPT series combined vaccines, Hand-foot-mouth series vaccines, Pneumococcal series vaccines, MMR series live attenuate


  • Scientific Achievements

    Since its establishment, the company has independently developed 7 China-first and World-first vaccine products, and obtained 5 National New Drug Certificates, including 2 First-Class New Drug Certifi


  • Our Partners

    Institute of Biophysics, Chinese Academy of Sciences Institute of Microbiology, Chinese Academy of SciencesThe Second Affiliated Hospital, Army Medical University (Xinqiao Hospital) the PLA Academy of